308 related articles for article (PubMed ID: 4798099)
1. The central action of 5-allyl-5-(beta-hydroxypropyl)-N-phenylbarbituric acid and the corresponding lactone.
Sieroslawska J; Czarnecki R; Sypniewska M; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1973; 25(2):113-26. PubMed ID: 4798099
[No Abstract] [Full Text] [Related]
2. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
[No Abstract] [Full Text] [Related]
3. The central action of 1-p-dimethylaminophenyl-5-allyl-5-(beta-hydroxypropyl) barbituric acid and the corresponding lactone.
Hano J; Sypniewska M; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1978; 30(1):55-61. PubMed ID: 565512
[TBL] [Abstract][Full Text] [Related]
4. In the search for new tranquilizing drugs.
Sieroslawska J; Hano J
Mater Med Pol; 1972; 4(1):3-9. PubMed ID: 4664412
[No Abstract] [Full Text] [Related]
5. Pharmacologic properties of the dilactone of bis-(beta-hydroxypropyl)-malonic acid.
Pelczarska A; Prastowski W
Arch Immunol Ther Exp (Warsz); 1967; 15(6):912-9. PubMed ID: 5586112
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
Chiba S; Nagawa Y; Yui T
Nihon Yakurigaku Zasshi; 1970; 66(1):64-75. PubMed ID: 4393359
[No Abstract] [Full Text] [Related]
7. Pharmacological and behavioral effects of mono- and disubstituted chlorpromazine derivatives.
Buckley JP; Steenberg ML; Barry H; Manian AA
Adv Biochem Psychopharmacol; 1974; 9(0):617-31. PubMed ID: 4836226
[No Abstract] [Full Text] [Related]
8. The neuroleptics. 5. Animal behavior.
Buser P; Cook L; Giurgea C; Jacobsen E; Ray OS; Richelle M; Silverman AP; Stein L; Votava Z
Mod Probl Pharmacopsychiatry; 1970; 5():85-108. PubMed ID: 5005610
[No Abstract] [Full Text] [Related]
9. Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164).
Saito C; Sakai S; Yukawa Y; Yamamoto H; Takagi H
Arzneimittelforschung; 1969 Dec; 19(12):1945-9. PubMed ID: 4985336
[No Abstract] [Full Text] [Related]
10. Pharmacological properties of gamma-animobutyric acid and it derivatives. IV. Aryl gaba derivatives and their respective lactams.
Chojnacka-Wójcik E; Hano J; Sieroslawska J; Sypniewska M
Arch Immunol Ther Exp (Warsz); 1975; 23(6):733-46. PubMed ID: 1241266
[TBL] [Abstract][Full Text] [Related]
11. Resolution of optical isomers of 5-allyl-5-(beta-hydroxypropyl)-barbituric acid (Ipronal, Axeen) and their pharmacological activity.
Bobranski B; Wilimowski M; Barczynska J; Seniuta R; Sedzimirska B; Witkowska M
Arch Immunol Ther Exp (Warsz); 1973; 21(2):299-308. PubMed ID: 4147382
[No Abstract] [Full Text] [Related]
12. Pharmacological and toxicological study of a new psychotropic stimulant: the 2-phenyl-5-dimethyl-tetrahydro-1,4-oxazine, in comparison with d,l-amphetamine, phenmetrazine and pemoline-Mg.
Fanelli O
Arzneimittelforschung; 1973 Jun; 23(6):810-6. PubMed ID: 4740767
[No Abstract] [Full Text] [Related]
13. Synthesis of new arylanalogs of ketamine.
Burak K; Lipnicka U; Orszańska H; Rykowski Z; Witkiewicz K; Wrzesień J; Bogdal M; Krzywasiński L; Borkowska B
Farmaco Sci; 1985 Apr; 40(4):285-98. PubMed ID: 4040474
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
Mikhaĭlova TV; Terekhina AI; Gilev AP
Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
[No Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of 7-azaanalogues of ipsapirone.
Malinka W; Sielklucka-Dziuba M; Rajtar G; Marowska D; Kleinrok Z
Farmaco; 1995 Nov; 50(11):769-78. PubMed ID: 8593174
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of certain central effects of atropine, scopolamine and their quaternary ammonium derivatives in animals].
Malatray J; Simon P
Therapie; 1972; 27(1):153-66. PubMed ID: 5017551
[No Abstract] [Full Text] [Related]
17. Pharmacological properties of bis-beta-hydroxypropylmalonic acid dilactone derivatives.
Sypniewska M
Pol J Pharmacol Pharm; 1976; 28(2):157-65. PubMed ID: 945562
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological properties of carbidine].
Barkov NK
Farmakol Toksikol; 1971; 34(6):647-50. PubMed ID: 5003741
[No Abstract] [Full Text] [Related]
19. On the central action of alkyl derivatives of butyrolactone.
Prastowski W
Arch Immunol Ther Exp (Warsz); 1968; 16(5):827-36. PubMed ID: 4387830
[No Abstract] [Full Text] [Related]
20. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
McKearney JW
J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
